• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发冠心病患者药物洗脱支架置入术后长期预后的危险因素。

Risk factors for long-term outcome of drug-eluting stenting in adults with early-onset coronary artery disease.

机构信息

1. The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Shandong University Qilu Hospital, Jinan, Shandong 250012, China; ; 2. Department of cardiology, Shandong University Qilu Hospital, Jinan, Shandong 250012, China;

3. Fine Arts School of Shandong University, Jinan, Shandong 250012, China.

出版信息

Int J Med Sci. 2014 May 10;11(7):721-5. doi: 10.7150/ijms.8718. eCollection 2014.

DOI:10.7150/ijms.8718
PMID:24904227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4045791/
Abstract

OBJECTIVE

We lack data on the long-term outcome of drug-eluting stenting in patients with early-onset coronary artery disease (CAD). Here, we investigated the association of traditional risk factors and major adverse cardiovascular events (MACEs) after drug-eluting stenting in patients with CAD who were < 50 years old.

METHODS

We enrolled 437 consecutive CAD patients < 50 years old who underwent drug-eluting stenting and 132 subjects who were age- and sex-matched and angiographically shown to be disease free as controls. MACEs were analyzed in CAD patients for a median of 24 months [interquartile range 14-34 months].

RESULTS

Male patients accounted for 90.4% of cases. As compared with controls, patients with early-onset CAD had higher body mass index and rates of smoking, family history of CAD, and diabetes and hypercholesterolemia. During the hospital stay, 1 patient died, and the incidence of MACEs was 1.1%. At the end of follow-up, the overall death rate was 0.7%. MACEs were observed in 54 patients (12.4%). On Cox proportional hazard analyses, positive family history and diabetes were independent risk factors of MACEs (HR 2.61, 95% confidence interval 1.29-4.00, p = 0.002; and HR 2.48, 95% confidence interval 0.86-3.14, p = 0.004, respectively).

CONCLUSIONS

Drug-eluting stenting is a reliable treatment for patients with early-onset CAD. Positive family history of CAD and diabetes are independent risk factors of adverse cardiovascular events in this subgroup of patients after drug-eluting stent implantation.

摘要

目的

我们缺乏关于早发冠心病(CAD)患者药物洗脱支架置入后长期结局的数据。在此,我们研究了<50 岁 CAD 患者药物洗脱支架置入后传统危险因素与主要不良心血管事件(MACE)的相关性。

方法

我们纳入了 437 例连续的<50 岁 CAD 患者行药物洗脱支架置入,并纳入 132 例年龄和性别匹配且血管造影显示无疾病的患者作为对照。CAD 患者的 MACE 进行了中位数为 24 个月(14-34 个月)的中位随访。

结果

男性患者占 90.4%。与对照组相比,早发 CAD 患者的体重指数更高,且吸烟、CAD 家族史、糖尿病和高胆固醇血症的发生率更高。住院期间,1 例患者死亡,MACE 发生率为 1.1%。随访结束时,总死亡率为 0.7%。54 例患者(12.4%)观察到 MACE。Cox 比例风险分析显示,阳性 CAD 家族史和糖尿病是 MACE 的独立危险因素(HR 2.61,95%置信区间 1.29-4.00,p=0.002;和 HR 2.48,95%置信区间 0.86-3.14,p=0.004)。

结论

药物洗脱支架置入术是治疗早发 CAD 患者的可靠方法。CAD 阳性家族史和糖尿病是该亚组患者药物洗脱支架置入后不良心血管事件的独立危险因素。

相似文献

1
Risk factors for long-term outcome of drug-eluting stenting in adults with early-onset coronary artery disease.早发冠心病患者药物洗脱支架置入术后长期预后的危险因素。
Int J Med Sci. 2014 May 10;11(7):721-5. doi: 10.7150/ijms.8718. eCollection 2014.
2
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用:系列 PRECOMBAT(使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究)的汇总分析。
Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.
3
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.紫杉醇涂层球囊血管成形术与药物洗脱支架置入术治疗冠状动脉药物洗脱支架内慢性完全闭塞的临床转归。
Cardiovasc Drugs Ther. 2023 Dec;37(6):1155-1166. doi: 10.1007/s10557-022-07363-7. Epub 2022 Aug 5.
4
Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.无保护左主干冠状动脉分叉病变中,西罗莫司洗脱支架与紫杉醇洗脱支架的长期疗效对比。
Clin Cardiol. 2011 Jun;34(6):378-83. doi: 10.1002/clc.20887. Epub 2011 Apr 27.
5
Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.药物洗脱支架与裸金属支架治疗ST段抬高型心肌梗死的长期疗效比较:紫杉醇或西罗莫司洗脱支架与裸金属支架在直接经皮冠状动脉介入治疗(PASEO)随机试验中的结果
Circulation. 2009 Sep 15;120(11):964-72. doi: 10.1161/CIRCULATIONAHA.108.830372. Epub 2009 Aug 31.
6
Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.比较接受西罗莫司洗脱支架治疗后伴有和不伴有无保护左主干冠状动脉疾病患者的 5 年结局:来自 j-Cypher 注册研究的结果。
JACC Cardiovasc Interv. 2013 Jul;6(7):654-63. doi: 10.1016/j.jcin.2013.03.015.
7
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).比较依维莫司和西罗莫司洗脱支架血运重建后合并与不合并糖尿病患者的结局(来自 SORT OUT IV 试验)。
Am J Cardiol. 2012 Dec 1;110(11):1585-91. doi: 10.1016/j.amjcard.2012.07.022. Epub 2012 Sep 4.
8
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).在冠状动脉疾病的未选择人群中,比较雷帕霉素洗脱支架与紫杉醇洗脱支架 3 年临床结果(REWARDS 注册研究)
Am J Cardiol. 2010 Aug 15;106(4):504-10. doi: 10.1016/j.amjcard.2010.04.001.
9
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).比较药物洗脱支架植入术后高再狭窄风险患者的三联抗血小板治疗与双联抗血小板治疗(来自 DECLARE-DIABETES 和 -LONG 试验)。
Am J Cardiol. 2010 Jan 15;105(2):168-73. doi: 10.1016/j.amjcard.2009.08.667. Epub 2009 Dec 3.
10
Comparison of restenosis rate with sirolimus-eluting stent in STEMI patients with and without diabetes at 6-month angiographic follow-up.
Acta Cardiol. 2011 Oct;66(5):603-6. doi: 10.1080/ac.66.5.2131085.

引用本文的文献

1
Dietary patterns and premature coronary artery disease: result from the Iran premature coronary artery disease (IPAD) study.饮食模式与早发冠心病:来自伊朗早发冠心病(IPAD)研究的结果。
BMC Cardiovasc Disord. 2024 Nov 27;24(1):683. doi: 10.1186/s12872-024-04333-9.
2
Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq.伊拉克库尔德斯坦地区接受冠状动脉造影术患者中早发冠状动脉疾病的患病率及危险因素
BMC Cardiovasc Disord. 2015 Nov 18;15:155. doi: 10.1186/s12872-015-0145-7.

本文引用的文献

1
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
Glob Heart. 2012 Dec;7(4):275-95. doi: 10.1016/j.gheart.2012.08.001. Epub 2012 Sep 26.
2
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.荟萃分析比较第一代药物洗脱支架与裸金属支架在糖尿病患者行直接经皮冠状动脉介入治疗中的疗效和安全性。
Am J Cardiol. 2013 May 1;111(9):1295-304. doi: 10.1016/j.amjcard.2013.01.281. Epub 2013 Mar 12.
3
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗在三支病变合并左主干病变患者中的比较:随机、临床 SYNTAX 试验的 5 年随访结果。
Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.
4
Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study.家族史与男性长期随访中心血管疾病死亡的关系:库珀中心纵向研究。
Circulation. 2012 Jun 26;125(25):3092-8. doi: 10.1161/CIRCULATIONAHA.111.065490. Epub 2012 May 23.
5
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.药物洗脱支架和金属裸支架的短期和长期结果:来自随机试验的 117762 患者年随访的混合治疗比较分析。
Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.
6
Long-term outcomes of percutaneous coronary interventions with stent implantation in patients ≤40 years old.≤40 岁患者经皮冠状动脉介入治疗伴支架植入的长期疗效。
Am J Cardiol. 2012 Jun 15;109(12):1717-21. doi: 10.1016/j.amjcard.2012.01.400. Epub 2012 Mar 20.
7
The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).生物可降解聚合物雷帕霉素洗脱支架与永久性聚合物西罗莫司洗脱支架(LEADERS)随机“所有患者”试验的 3 年随访结果。
EuroIntervention. 2011 Nov;7(7):789-95. doi: 10.4244/EIJV7I7A125.
8
A positive family history for premature cardiovascular disease identifies patients prone to recurrent arterial thrombotic events.有早发性心血管疾病阳性家族史可识别易发生复发性动脉血栓栓塞事件的患者。
Eur J Prev Cardiol. 2012 Dec;19(6):1465-73. doi: 10.1177/1741826711422989. Epub 2011 Sep 13.
9
Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.无限制随机使用两种新一代药物洗脱冠状动脉支架:RESOLUTE 所有患者试验 2 年的患者相关与支架相关结局。
Lancet. 2011 Apr 9;377(9773):1241-7. doi: 10.1016/S0140-6736(11)60395-4. Epub 2011 Apr 1.
10
Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients ≤50 years of age having percutaneous coronary intervention.在接受经皮冠状动脉介入治疗的≤50 岁患者中,时间趋势(30 多年)、临床特征、结局和性别。
Am J Cardiol. 2011 Mar 1;107(5):668-74. doi: 10.1016/j.amjcard.2010.10.044. Epub 2011 Jan 17.